72
https://pubmed.ncbi.nlm.nih.gov/38116361
A patient with multiple myeloma developed a severe, fatal skin rash after treatment with the proteasome inhibitor bortezomib.
“Fatal Skin Rash in Multiple Myeloma Patient Treated with Bortezomib”
